Polar Asset Management Partners’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Polar Asset Management Partners’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,740	Closed	-$223K	–	775
2024 Q3	$223K	Hold	7,740	–	–	﹤0.01%	488
2024 Q2	$198K	Hold	7,740	–	–	﹤0.01%	453
2024 Q1	$585K	Hold	7,740	–	–	0.01%	459
2023 Q4	$797K	Buy	+7,740	New	+$695K	0.01%	446
2020 Q3	–	Sell	-22,996	Closed	-$4.94M	–	693
2020 Q2	$4.94M	Buy	22,996 +4,951	+27%	+$1.05M	0.08%	227
2020 Q1	$3.8M	Sell	18,045 -995	-5%	-$209K	0.08%	213
2019 Q4	$3.99M	Buy	19,040 +16,540	+662%	+$3.45M	0.08%	235
2019 Q3	$518K	Hold	2,500	–	–	0.01%	340
2019 Q2	$513K	Hold	2,500	–	–	0.01%	308
2019 Q1	$504K	Hold	2,500	–	–	0.01%	268
2018 Q4	$492K	Buy	+2,500	New	+$490K	0.01%	264

Other funds holding RVPH

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.19% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PAP

Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Polar Asset Management Partners's RVPH Position: Q4 2024 in Review

Polar Asset Management Partners sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2024, closing a stake of 7,740 shares — an estimated $223K sold.

Polar Asset Management Partners first reported a position in RVPH in Q4 2018 and held it in 11 quarters. The position peaked at $4.94M in Q2 2020. 42 funds tracked by Wall St. Rank hold RVPH as of Q4 2024.

Polar Asset Management Partners reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2024 after selling out during the quarter.
Polar Asset Management Partners sold 7,740 REVIVA PHARMA HLDGS INC shares in Q4 2024, an estimated $223K.
Polar Asset Management Partners first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 11 quarters.
Polar Asset Management Partners's REVIVA PHARMA HLDGS INC position peaked at $4.94M in Q2 2020.
42 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2024.

Based on Polar Asset Management Partners's 13F filing for Q4 2024, filed 14 Feb 2025.